The company promoted by GSK Velu, who was an investor in diagnostic chain Metropolis ... with a presence not just in the Indian market but also in the UAE, US, and South Africa. The chain has the ...

To subscribe, simply enter your email address on our website or click the subscribe button below. Don't worry, we respect your privacy and won't spam your inbox. Your information is safe with us.

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

Nigeria’s pharmaceutical companies are ramping up investments and expanding operations to tap growing local opportunities.

The nicotine replacement products market is poised for significant expansion from 2024 to 2033. While exact figures are proprietary, industry experts project a compound annual growth rate (CAGR) in ...

GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...

GSK has expanded a collaboration with BioVersys ... beyond a current phase 2a trial in pulmonary TB, which is ongoing in South Africa. The extension to the Series C takes the total raised by ...

Neuberg Diagnostics is in talks with a consortium of investors, including funds managed by 360One and foreign investor M&G ...

Darth Vader and Mufasa voice actor dies The 20 Most Expensive Cars Ever Made Mpox cases on the rise in South Africa From hustling to homesteading — how algorithms tried to turn me into a # ...

The Nigerian naira has plunged hard in the past few months and is now sitting at its all-time low against the US dollar.

In a study of more than 3,000 participants, Gilead's twice-yearly lenacapavir delivered a 96% reduction in HIV infections compared with background HIV incidence.